Related Experiment Video
Updated: Jun 25, 2026

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
Published on: October 27, 2023
Alkaloid derivatives in Qing-Luo-Yin alleviated experimental arthritis in rodents by activating PPARγ
Lijun Yu1,2, Tingting Luo2,3, Dandan Wang2,3
1School of Pharmacy, Anhui College of Traditional Chinese Medicine, Wuhu, China.
Abstract:
The herbal formula Qing-Luo-Yin (QLY) shows potential in activating PPARγ. This study investigated how this property contributed to its anti-rheumatic effects. Some mice with antigen-induced arthritis (AA) were orally treated with QLY and/or PPARγ antagonist/agonist (T0070907/rosiglitazone). PPARγ agonists were screened out by molecular docking and validated by experiments in vitro. Rosiglitazone and QLY ameliorated arthritis, inflammation and lipid depletion of AA mice. The effects of QLY were weakened by T0070907. Among the compounds abundant in QLY extract and QLY-treated adjuvant-induced arthritis (AIA) rats' serum, matrine, sophocarpine and sinomenine exhibited high affinities to PPARγ, and elevated its thermal stability and transcriptional activity. They suppressed fat utilisation in AIA serum-incubated HepG2 hepatocytes. Accumulated fatty acids in the medium reduced TNF-ɑ, IL-6 and IL-1β secretion of lipopolysaccharide-stimulated THP-1 monocytes by inhibiting p65 phosphorylation. In short, certain alkaloids in QLY activate PPARγ signalling, which contributes to the improvements of both immune and metabolic environments.
More Related Videos
06:14Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
Published on: January 12, 2024
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity
Two...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.